Atea Pharmaceuticals Statistics
Total Valuation
AVIR has a market cap or net worth of $266.90 million. The enterprise value is -$214.07 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AVIR has 84.46 million shares outstanding. The number of shares has increased by 0.79% in one year.
| Current Share Class | 84.46M |
| Shares Outstanding | 84.46M |
| Shares Change (YoY) | +0.79% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 9.54% |
| Owned by Institutions (%) | 54.81% |
| Float | 64.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.58 |
| P/TBV Ratio | 0.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.33, with a Debt / Equity ratio of 0.00.
| Current Ratio | 19.33 |
| Quick Ratio | 19.17 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.45% and return on invested capital (ROIC) is -14.99%.
| Return on Equity (ROE) | -33.45% |
| Return on Assets (ROA) | -14.25% |
| Return on Capital (ROIC) | -14.99% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.32M |
| Employee Count | 75 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVIR has paid $1.05 million in taxes.
| Income Tax | 1.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.29% in the last 52 weeks. The beta is 0.17, so AVIR's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | +4.29% |
| 50-Day Moving Average | 3.47 |
| 200-Day Moving Average | 3.70 |
| Relative Strength Index (RSI) | 38.23 |
| Average Volume (20 Days) | 178,715 |
Short Selling Information
The latest short interest is 2.59 million, so 3.07% of the outstanding shares have been sold short.
| Short Interest | 2.59M |
| Short Previous Month | 2.63M |
| Short % of Shares Out | 3.07% |
| Short % of Float | 4.03% |
| Short Ratio (days to cover) | 18.59 |
Income Statement
| Revenue | n/a |
| Gross Profit | -78.28M |
| Operating Income | -125.30M |
| Pretax Income | -174.95M |
| Net Income | -174.01M |
| EBITDA | -124.88M |
| EBIT | -125.30M |
| Earnings Per Share (EPS) | -$2.07 |
Full Income StatementBalance Sheet
The company has $482.81 million in cash and $1.84 million in debt, giving a net cash position of $480.98 million or $5.69 per share.
| Cash & Cash Equivalents | 482.81M |
| Total Debt | 1.84M |
| Net Cash | 480.98M |
| Net Cash Per Share | $5.69 |
| Equity (Book Value) | 458.52M |
| Book Value Per Share | 5.43 |
| Working Capital | 461.72M |
Full Balance SheetCash Flow
| Operating Cash Flow | -126.94M |
| Capital Expenditures | n/a |
| Free Cash Flow | -126.94M |
| FCF Per Share | -$1.50 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |